Abbvie, Inc. (ABBV) Earnings
|
Expand Research on ABBV
| Next EPS Date | 4/26/24 | EPS Growth Rate | -7.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +1.2% | Revenue Growth Rate | -2.5% |
| Average % Move 1-Wk after EPS | +0.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/9/23 | Q422 | $3.60 | $3.53 | +$0.07 | $15.12B | $15.33B |  |
 | | Details | |
| 2/2/22 |  |
Q421 | $3.31 | $3.28 | +$0.03 | $14.89B | $14.95B | = | | | Details |
| 10/28/22 | Q322 | $3.66 | $3.58 | +$0.08 | $14.81B | $14.93B | = | | | Details | |
| 7/29/22 | Q222 | $3.37 | $3.34 | +$0.03 | $14.58B | $14.67B | = | | | Details | |
| 10/29/21 | |
Q321 | $3.33 | $3.23 | +$0.10 | $14.34B | $14.35B | = | | | Details |
| 2/2/24 | Q423 | $2.79 | $2.77 | +$0.02 | $14.3B | $14.01B | = | | | Details | |
| 2/3/21 | |
Q420 | $2.92 | $2.86 | +$0.06 | $13.86B | $13.73B | = | | | Details |
| 10/27/23 | Q323 | $2.95 | $2.87 | +$0.08 | $13.93B | $13.71B | |
| | Details |
